[The radiotherapy FLASH to save healthy tissues].
Inserm U 612, Institut Curie-Recherche, bâtiments 110-112, centre universitaire, 91405 Orsay, France.
Vincent
V
Favaudon
Inserm U 612, Institut Curie-Recherche, bâtiments 110-112, centre universitaire, 91405 Orsay, France.
Charles
C
Fouillade
Radio-oncologie/radiothérapie, centre hospitalier universitaire vaudois, 1011 Lausanne, Suisse.
Marie-Catherine
MC
Vozenin
D000818:Animals; D017209:Apoptosis / Q000528:radiation effects; D002478:Cells, Cultured; D002875:Chromosomes / Q000528:radiation effects; D019583:Dose Fractionation, Radiation; D004583:Electrons / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008168:Lung / Q000378:metabolism / Q000528:radiation effects; D051379:Mice; D058958:Organs at Risk / Q000528:radiation effects; D010315:Particle Accelerators; D011833:Radiation Injuries, Experimental / Q000517:prevention & control*; D017564:Radiation Pneumonitis / Q000209:etiology / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control; D011878:Radiotherapy / Q000009:adverse effects / Q000379:methods*; D016212:Transforming Growth Factor beta / Q000096:biosynthesis; D057170:Translational Research, Biomedical; D023041:Xenograft Model Antitumor Assays
D016212:Transforming Growth Factor beta